Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Apr 20, 2023
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2023-04-17+213,000→ 414,666 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 17,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.